Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations

Neurology

Volumn 69, Issue 22, 2007, Pages 2045-2053

  Wuttke, T V ^a   Jurkat Rott, K ^a   Paulus, W ^b   Garncarek, M ^a   Lehmann Horn, F ^a   Lerche, H ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTICONVULSIVE AGENT; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV7.2; POTASSIUM CHANNEL KV7.3; RETIGABINE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; ATAXIA; BENIGN CHILDHOOD EPILEPSY; CONTROLLED STUDY; DEPOLARIZATION; ELECTROMYOGRAPHY; EPILEPSY; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HUMAN; IDIOPATHIC DISEASE; ION CONDUCTANCE; KCNQ2 GENE; MOTONEURON; MUSCLE DISEASE; MUSCLE OVERACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PERIPHERAL NERVE HYPEREXCITABILITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SENSOR; VOLTAGE CLAMP; WILD TYPE; XENOPUS LAEVIS;

EID: 36448983645     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000275523.95103.36     Document Type: Article

References (40)

1. Auger RG, Daube JR, Gomez MR, Lambert EH. Hereditary form of sustained muscle activity of peripheral nerve origin causing generalized myokymia and muscle stiffness. Ann Neurol 1984;15:13-21.
2. Hart IK, Newsom-Davis J. Generalized peripheral nerve hyperexcitability (neuromyotonia). In: Engel A, Franzini-Armstrong C, eds. Myology: basic and clinical, 3rd ed. New York: McGraw-Hill Medical Pub. Division; 2004:1301-1309.
3. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 2002;125:1887-1895.
4. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiatry 1961;24:319-325.
5. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001;124:2417-2426.
6. Mertens HG, Zschocke S. [Neuromyotonia]. Klin Wochenschr 1965;43:917-925.
7. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 1993;116(Pt 2):453-469.
8. Tahmoush AJ, Alonso RJ, Tahmoush GP, Heiman-Patterson TD. Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 1991;41:1021-1024.
9. Vincent A, Beeson D, Lang B. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission. Eur J Biochem 2000;267:6717-6728.
10. Storm JF. Potassium currents in hippocampal pyramidal cells. Prog Brain Res 1990;83:161-187.
11. Browne DL, Gancher ST, Nutt JG. Episodic ataxia/ myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994;8:136-140.
12. Lehmann-Horn F, Jurkat-Rott K. Voltage-gated ion channels and hereditary disease. Physiol Rev 1999;79:1317-1372.
13. Eunson LH, Rea R, Zuberi SM. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 2000;48:647-656.
14. Kullmann DM. The neuronal channelopathies. Brain 2002;125:1177-1195.
15. Dedek K, Kunath B, Kananura C, Reuner U, Jentsch TJ, Steinlein OK. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci USA 2001;98:12272-12277.
16. Delmas P, Brown DA. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat Rev Neurosci 2005;6:850-862.
17. Ronen GM, Rosales TO, Connolly M, Anderson VE, Leppert M. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 1993;43:1355-1360.
18. Biervert C, Schroeder BC, Kubisch C. A potassium channel mutation in neonatal human epilepsy. Science 1998;279:403-406.
19. Charlier C, Singh NA, Ryan SG. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998;18:53-55.
20. Singh NA, Charlier C, Stauffer D. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998;18:25-29.
21. Jentsch TJ. Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 2000;1:21-30.
22. Singh NA, Westenskow P, Charlier C. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003;126:2726-2737.
23. Steinlein OK. Genetic mechanisms that underlie epilepsy. Nat Rev Neurosci 2004;5:400-408.
24. Lerche H, Weber YG, Jurkat-Rott K, Lehmann-Horn F. Ion channel defects in idiopathic epilepsies. Curr Pharm Des 2005;11:2737-2752.
25. Devaux JJ, Kleopa KA, Cooper EC, Scherer SS. KCNQ2 is a nodal K+ channel. J Neurosci 2004;24:1236-1244.
26. Lerche H, Biervert C, Alekov AK, et al. A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol 1999;46:305-312.
27. Wuttke TV, Seebohm G, Bail S, Maljevic S, Lerche H. The new anticonvulsant retigabine favors voltagedependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol Pharmacol 2005;67:1009-1017.
28. Wang HS, Pan Z, Shi W, et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 1998;282:1890-1893.
29. Yang WP, Levesque PC, Little WA, et al. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy. J Biol Chem 1998;273:19419-19423.
30. Peretz A, Sheinin A, Yue C, et al. Pre- and postsynaptic activation of M-channels by a novel opener dampens neuronal firing and transmitter release. J Neurophysiol 2007;97:283-295.
31. Vervaeke K, Gu N, Agdestein C, Hu H, Storm JF. Kv7/ KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release. J Physiol 2006;576:235-256.
32. MacKinnon R. Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature 1991;350:232-235.
33. Papazian DM. Potassium channels: some assembly required. Neuron 1999;23:7-10.
34. Tytgat J, Hess P. Evidence for cooperative interactions in potassium channel gating. Nature 1992;359:420-423.
35. Mannuzzu LM, Isacoff EY. Independence and cooperativity in rearrangements of a potassium channel voltage sensor revealed by single subunit fluorescence. J Gen Physiol 2000;115:257-268.
36. Ledwell JL, Aldrich RW. Mutations in the S4 region isolate the final voltage-dependent cooperative step in potassium channel activation. J Gen Physiol 1999;113:389-414.
37. Wuttke TV, Lerche H. Novel anticonvulsant drugs targeting voltage-dependent ion channels. Expert Opin Investig Drugs 2006;15:1167-1177.
38. Rundfeldt C. Characterization of the K+ channel opening effect of the anticonvulsant retigabine in PC12 cells. Epilepsy Res 1999;35:99-107.
39. Rundfeldt C, Netzer R. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits. Neurosci Lett 2000;282:73-76.
40. Schenzer A, Friedrich T, Pusch M, Saftig P, Jentsch TJ, Grötzinger J, Schwake M. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J Neurosci. 2005;25:5051-5060.